N6-Methyladenosine-Mediated CELF2 Regulates CD44 Alternative Splicing Affecting Tumorigenesis via ERAD Pathway in Pancreatic Cancer

Using in vivo and in vitro experiments, the authors demonstrated that abnormal expression of (CUGBP) Elav-like family member 2 (CELF2) affected the stemness, apoptosis, and proliferation of pancreatic cancer cells.